(Q34821414)

4 August 2017

1 reference

title

Hormonal replacement therapy. (English)

1 reference

4 August 2017

Regine Sitruk-Ware

1

1 reference

4 August 2017

1 September 2002

1 reference

Reviews in Endocrine and Metabolic Disorders

4 August 2017

1 reference

4 August 2017

3

1 reference

4 August 2017

3

1 reference

4 August 2017

243-256

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1020028510797

4 August 2017

0 references

cites work

The time has come to stop letting the HERS tale wag the dogma

1 reference

12 December 2020

Nestorone: a progestin with a unique pharmacological profile

1 reference

12 December 2020

Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women.

1 reference

12 December 2020

Circulating Estradiol, Estrone and Gonadotropin Levels Following the Administration of Orally Active 17β-Estradiol in Postmenopausal Women

1 reference

12 December 2020

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Topical hormonal treatment and urogenital atrophy

1 reference

12 December 2020

Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

1 reference

12 December 2020

Alternatives to the use of estrogen in postmenopausal women

1 reference

12 December 2020

Metabolic influences on the action of estrogens: therapeutic implications

1 reference

12 December 2020

The long-term effects of oral and transdermal postmenopausal hormone replacement therapy on nitric oxide, endothelin-1, prostacyclin, and thromboxane

1 reference

12 December 2020

Carbohydrate metabolism during hormonal substitution therapy

1 reference

12 December 2020

Coadministration of nomegestrol acetate does not diminish the beneficial effects of estradiol on coronary artery dilator responses in nonhuman primates (Macaca fascicularis)

1 reference

12 December 2020

Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women

1 reference

12 December 2020

The primary prevention of coronary heart disease in women

1 reference

12 December 2020

The protective effects of estrogen on the cardiovascular system

1 reference

12 December 2020

Achieving long-term continuance of menopausal ERT/HRT: consensus opinion of the North American Menopause Society

1 reference

12 December 2020

Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations

1 reference

12 December 2020

Female sex steroid receptors in normal, hyperplastic and carcinomatous endometrium. The relationship to serum steroid hormones and gonadotropins and changes during medroxyprogesterone acetate administration

1 reference

12 December 2020

Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. Postmenopausal Estrogen/Progestin Interventions Trial

1 reference

12 December 2020

Absorption of percutaneous oestradiol in postmenopausal women

1 reference

12 December 2020

Synthesis and biological activity of a new progestogen, 16-methylene-17alpha-hydroxy-18-methyl-19-norpregn-4-ene-3, 20-dione acetate

1 reference

12 December 2020

Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause

1 reference

12 December 2020

Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study

1 reference

12 December 2020

Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate

1 reference

12 December 2020

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

12 December 2020

Duration of hormonal replacement therapy in general practice; a follow-up study

1 reference

12 December 2020

Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study

1 reference

12 December 2020

Progestogens in hormonal replacement therapy: new molecules, risks, and benefits

1 reference

12 December 2020

Higher levels of plasma estradiol and testosterone in healthy elderly men compared with age-matched women may protect aspects of explicit memory.

1 reference

12 December 2020

Estrogens and endometrial carcinoma

1 reference

12 December 2020

Treatment of postmenopausal osteoporosis with transdermal estrogen

1 reference

12 December 2020

Quality of life after the menopause: influence of hormonal replacement therapy.

1 reference

12 December 2020

The pharmacological profile of TX 066 (17 alpha-acetoxy-6-methyl-19-nor-4,6-pregna-diene-3,20-dione), a new oral progestative.

1 reference

12 December 2020

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy

1 reference

12 December 2020

Menopause, hormone replacement therapy and cancer

1 reference

12 December 2020

Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate

1 reference

12 December 2020

Norgestrel and gestodene stimulate breast cancer cell growth through an oestrogen receptor mediated mechanism

1 reference

12 December 2020

Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy

1 reference

12 December 2020

A randomized comparison of nonoral estradiol delivery in postmenopausal women

1 reference

12 December 2020

Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement

1 reference

12 December 2020

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

12 December 2020

Hormone replacement therapy. Clinical Synthesis Panel on HRT

1 reference

12 December 2020

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

1 reference

12 December 2020

Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group

1 reference

12 December 2020

The Effect of Medroxyprogesterone Acetate on the Pituitary-Adrenal Axis

1 reference

12 December 2020

Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol andd-norgestrel

1 reference

12 December 2020

The biological activity of 7 alpha-methyl-19-nortestosterone is not amplified in male reproductive tract as is that of testosterone

1 reference

12 December 2020

Living arrangements of older adults in the developing world: an analysis of demographic and health survey household surveys.

1 reference

12 December 2020

Estradiol pharmacokinetics after transdermal application of patches to postmenopausal women: matrix versus reservoir patches

1 reference

12 December 2020

Efficacy of continuous sequential transdermal estradiol and norethindrone acetate in relieving vasomotor symptoms associated with menopause

1 reference

12 December 2020

Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity

1 reference

12 December 2020

Comparison of two continuous combined estrogen progestogen regimens in postmenopausal women: a randomized trial

1 reference

12 December 2020

Selective oestrogen receptor modulators

1 reference

12 December 2020

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

12 December 2020

Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast disease

1 reference

12 December 2020

Estradiol-delivering vaginal rings for hormone replacement therapy

1 reference

12 December 2020

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

1 reference

12 December 2020

Female sex steroids: receptors and function

1 reference

12 December 2020

Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism

1 reference

12 December 2020

Hormone therapy and in-hospital survival after myocardial infarction in postmenopausal women

1 reference

12 December 2020

A meta-analysis of estrogen replacement therapy and risk of epithelial ovarian cancer

1 reference

12 December 2020

Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: Comparison with conventional oral estrogens used for hormone replacement

1 reference

12 December 2020

Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer

1 reference

12 December 2020

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

1 reference

12 December 2020

Transdermal testosterone treatment in women with impaired sexual function after oophorectomy

1 reference

12 December 2020

Current perspectives on benefits and risks of hormone replacement therapy

1 reference

12 December 2020

Absorption of Estrogens from Vaginal Creams

1 reference

12 December 2020

Menopause and the risk of coronary heart disease in women

1 reference

12 December 2020

Effects of estrogen replacement on the progression of coronary-artery atherosclerosis

1 reference

12 December 2020

Hormone replacement therapy and risk of venous thromboembolism: population based case-control study

1 reference

12 December 2020

Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials

1 reference

12 December 2020

Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy

1 reference

12 December 2020

Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk

1 reference

12 December 2020

Efficacy and acceptability of intranasal 17 beta-oestradiol for menopausal symptoms: randomised dose-response study. Aerodiol Study Group

1 reference

12 December 2020

Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women

1 reference

12 December 2020

Cigarette smoking, alcohol consumption, and risk of hip fracture in women.

1 reference

12 December 2020

Long-term effects of transdermal estradiol with and without medroxyprogesterone acetate

1 reference

12 December 2020

Antiandrogenic properties of nomegestrol acetate

1 reference

12 December 2020

A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. I. An assessment of the quality of randomized trials published between 1977 and 1995.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1020028510797

1 reference

PubMed ID

12215719

Dimensions Publication ID

4 August 2017

0 references

1 reference

PubMed ID

12215719